
Conference Coverage
about 5 hours ago
DermNexus 2026 to Explore Innovations in Inflammatory Skin Disease22 days ago
Elevate-Derm Summer Clinical Pearlsabout 1 month ago
Securing GLP-1 Access and Exploring Hidradenitis Suppurativa TrialsLatest News

Gene Expression Profiling and Adjuvant Radiation Decisions in CSCC

DermNexus 2026 to Explore Innovations in Inflammatory Skin Disease

Guselkumab in Axial Psoriatic Arthritis: Phase 4 STAR Trial Results

Experts Explore Individualized Treatment Strategies for Psoriasis

Q&A: What Phase 2 Nemolizumab Data Mean for Young Children With Eczema
Videos

Shorts










Dermatology Times Digital Edition









All News

Palvella unveiled QTORIN docetaxel, a topical candidate for extramammary Paget’s disease, with FDA talks planned in early 2027 ahead of a phase 2 study.

For Healthy Skin Month, a dermatologist discusses winter sun protection, overlooked patients in skin cancer screening, bemotrizinol, and AI in detection.

Clinicians at a Dermatology Times Case-Based Roundtable, moderated by Jessica Mercer, MD, debated severity scoring, trial data, and monitoring when selecting JAK inhibitors for alopecia areata.

For Healthy Skin Month, a dermatology nurse practitioner shares why sunscreen matters in winter and how clinicians can close gaps in skin cancer screening.

Learn why indoor tanning remains a preventable source of melanoma, what research suggests about why some patients experience difficulty stopping, and how a clinical pilot called TanPrevent could connect education with follow-up support to help them quit and stay quit.

Bioelements and Celluma partnered to educate estheticians on integrating LED light therapy into customized facial treatments for acne and aging skin.

FDA implements updated iPLEDGE REMS requirements for isotretinoin, allowing at-home pregnancy testing and reducing prescription and counseling burdens.

Bosakitug failed to meet primary and secondary endpoints in a phase 2 atopic dermatitis trial despite evidence of TSLP target engagement.

Recent dermatology research explores chronic hand eczema prevalence, cancer risk in morphea, pernio, biologic optimization in HS, and melanoma risk prediction.

Hypochlorous acid sprays are trending as a post-gym skin care essential, but can they actually prevent sweat-related breakouts?

Clinicians discuss how type 2 inflammation informs treatment decisions across AD, prurigo nodularis, CSU, and bullous pemphigoid.

A pediatric dermatologist explains how CALM count, size, age, and associated findings separate benign spots from neurofibromatosis type 1 and its mimics.

At a Dermatology Times Case-Based Roundtable, Vishal A. Patel, MD, led a discussion on treatment selection, tolerability, and individualized care for patients with advanced basal cell carcinoma.

Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.

October brought FDA approvals in urticaria and HSV, new regulatory filings, and phase 3 advances in HS, psoriasis, and rare diseases.























